Skip to main content
. 2019 Dec 17;35(3):409–415. doi: 10.46497/ArchRheumatol.2020.7215

Table 1. Demographic and clinical characteristics of patients (n=50).

  n % Median Min-Max IQR
Age (year)     50.5 27-68 17
Body mass index (kg/m2)     27.1 19.3-36.6 5.3
Disease duration (month)     60 1-444 84
Disease activity score-28     2.7 1.4-5.7 1.5
Tender joint count     0 0-10 2
Swollen joint count     0 0-10 0.3
Erythrocyte sedimentation rate     22 5-68 18.5
C-reactive protein     3 0-30 4
Clinical type          
Asymmetric oligoarthritis 33 66      
Symmetric polyarthritis 11 22      
Axial disease predominant 6 12      
Active psoriasis 31 62      
Dactylitis 5 10      
Active arthritis 11 22      
Treatment          
csDMARDs 32 64      
csDMARDs + steroids 5 10      
bDMARDs 13 26      
Min: Minimum; Max: Maximum; IQR: Interquartile range; csDMARDs: Conventional synthetic disease-modifying antirheumatic drugs; bDMARDs: Biological disease-modifying antirheumatic drugs.